gene_symbol
CD38
hgnc_id
HGNC:1667
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Daratumumab binds CD38 on target cells and triggers Fc-mediated ADCC, complement-dependent cytotoxicity, and antibody-dependent phagocytosis; crosslinking can also induce apoptosis of CD38+ cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Type II transmembrane glycoprotein; ectoenzyme (NADase/cyclase) activity inhibited by binding
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT07021677
disease_id_num_tar_ref
1603
drug_id_num_tar_ref
4338